Rock Springs Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-550,000
Closed -$15.4M 141
2022
Q1
$15.4M Sell
550,000
-390,000
-41% -$10.7M 0.39% 66
2021
Q4
$25.7M Sell
940,000
-280,000
-23% -$7.59M 0.59% 55
2021
Q3
$33.2M Hold
1,220,000
0.7% 48
2021
Q2
$20.9M Buy
1,220,000
+139,800
+13% +$2.62M 0.41% 74
2021
Q1
$22.6M Buy
1,080,200
+380,200
+54% +$8.77M 0.49% 68
2020
Q4
$16M Buy
700,000
+200,000
+40% +$3.81M 0.34% 91
2020
Q3
$8.15M Hold
500,000
0.21% 111
2020
Q2
$6.77M Hold
500,000
0.19% 120
2020
Q1
$5.92M Sell
500,000
-300,000
-38% -$6.65M 0.25% 91
2019
Q4
$19.9M Sell
800,000
-72,500
-8% -$1.47M 0.63% 63
2019
Q3
$14.8M Buy
872,500
+82,500
+10% +$1.5M 0.59% 57
2019
Q2
$18M Buy
790,000
+325,000
+70% +$8.77M 0.65% 56
2019
Q1
$14.9M Hold
465,000
0.58% 57
2018
Q4
$13.1M Buy
465,000
+5,000
+1% +$146K 0.62% 53
2018
Q3
$13.2M Buy
460,000
+50,000
+12% +$1.5M 0.48% 67
2018
Q2
$15.4M Hold
410,000
0.59% 66
2018
Q1
$16.1M Buy
410,000
+65,000
+19% +$2.37M 0.69% 52
2017
Q4
$11.2M Hold
345,000
0.51% 68
2017
Q3
$10.7M Hold
345,000
0.5% 68
2017
Q2
$9.64M Hold
345,000
0.49% 64
2017
Q1
$5.92M Hold
345,000
0.34% 81
2016
Q4
$4.17M Hold
345,000
0.28% 85
2016
Q3
$5.46M Buy
345,000
+5,000
+1% +$75.3K 0.34% 84
2016
Q2
$4.4M Hold
340,000
0.33% 88
2016
Q1
$6.46M Buy
340,000
+2,707
+0.8% +$49K 0.54% 61
2015
Q4
$7.59M Buy
337,293
+99,793
+42% +$1.97M 0.58% 61
2015
Q3
$5.56M Buy
237,500
+62,500
+36% +$1.72M 0.45% 73
2015
Q2
$5.01M Buy
+175,000
New +$4.59M 0.37% 89

Rock Springs Capital Management's XENT Position: Q2 2022 in Review

Rock Springs Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 550,000 shares — an estimated $15.4M sold.

Rock Springs Capital Management first reported a position in XENT in Q2 2015 and held it in 28 quarters. The position peaked at $33.2M in Q3 2021. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Rock Springs Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Rock Springs Capital Management sold 550,000 Intersect ENT, Inc shares in Q2 2022, an estimated $15.4M.
  • Rock Springs Capital Management first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 28 quarters.
  • Rock Springs Capital Management's Intersect ENT, Inc position peaked at $33.2M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Rock Springs Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.